Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorkell Andresson

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Nature Communications|November 27, 2021
BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcomaDominik Laubscher, Berkley E Gryder, Benjamin D Sunkel, et al.
Nature Communications|December 17, 2021
Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myelomaXiuxiu Lu, Venkata R Sabbasani, Vasty Osei-Amponsa, et al.
Journal of Medicinal Chemistry|December 3, 2009
Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesisVincent Sandanayaka, Bjorn Mamat, Rama K Mishra, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
CRISPR-Based Gene Dependency Screens reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid CancerShawn Noronha, Yue Liu, Gaga Geneti, et al.
Cell Chemical Biology|February 7, 2017
Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity ProfilingRhushikesh A Kulkarni, Andrew J Worth, Thomas T Zengeya, et al.
Redox Biology|January 24, 2025
Metabolic dependency mapping identifies Peroxiredoxin 1 as a driver of resistance to ATM inhibitionHaojian Li, Takashi Furusawa, Renzo Cavero, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Large-scale multi-omic analysis identifies noncoding somatic driver mutations and nominates <i>ZFP36L2</i> as a driver gene for pancreatic ductal adenocarcinomaJun Zhong, Aidan O'Brien, Minal Patel, et al.
Molecular Carcinogenesis|April 26, 2026
CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid CancerShawn Noronha, Yue Liu, Gaga Geneti, et al.
Gut|October 8, 2025
Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates <i>ZFP36L2</i> as a driver gene for pancreatic ductal adenocarcinomaJun Zhong, Aidan O'Brien, Minal B Patel, et al.
Cancer Research|March 21, 2014
CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cellsJinping Jia, Allen D Bosley, Abbey Thompson, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Nature Communications|November 27, 2021
BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcomaDominik Laubscher, Berkley E Gryder, Benjamin D Sunkel, et al.
Nature Communications|December 17, 2021
Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myelomaXiuxiu Lu, Venkata R Sabbasani, Vasty Osei-Amponsa, et al.
Journal of Medicinal Chemistry|December 3, 2009
Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesisVincent Sandanayaka, Bjorn Mamat, Rama K Mishra, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
CRISPR-Based Gene Dependency Screens reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid CancerShawn Noronha, Yue Liu, Gaga Geneti, et al.
Cell Chemical Biology|February 7, 2017
Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity ProfilingRhushikesh A Kulkarni, Andrew J Worth, Thomas T Zengeya, et al.
Redox Biology|January 24, 2025
Metabolic dependency mapping identifies Peroxiredoxin 1 as a driver of resistance to ATM inhibitionHaojian Li, Takashi Furusawa, Renzo Cavero, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Large-scale multi-omic analysis identifies noncoding somatic driver mutations and nominates <i>ZFP36L2</i> as a driver gene for pancreatic ductal adenocarcinomaJun Zhong, Aidan O'Brien, Minal Patel, et al.
Molecular Carcinogenesis|April 26, 2026
CRISPR-Based Gene Dependency Screens Reveal Mechanism of BRAF Inhibitor Resistance in Anaplastic Thyroid CancerShawn Noronha, Yue Liu, Gaga Geneti, et al.
Gut|October 8, 2025
Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates <i>ZFP36L2</i> as a driver gene for pancreatic ductal adenocarcinomaJun Zhong, Aidan O'Brien, Minal B Patel, et al.
Cancer Research|March 21, 2014
CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cellsJinping Jia, Allen D Bosley, Abbey Thompson, et al.
Pageof 12